Xiaoyao San Alleviates Depression-Associated Dry Eye via the LncRNA-Nespas/TAK1 Axis by Suppressing Central and Peripheral Inflammation.
Аннотация
Depression commonly manifests alongside dry eye disease (DED), and effective targeted treatments for this comorbid disorder are currently limited. Xiaoyao San (XYP), a traditional Chinese herbal formulation, is widely applied for the management of mood disturbances. This study explored the therapeutic effects and underlying molecular mechanism of XYP against depression-associated DED. A mouse model of comorbid depression and DED was generated by exposing animals to chronic unpredictable mild stress in a low-humidity environment. XYP notably ameliorated depressive-like phenotypes, restored tear secretion, and relieved corneal injury (p < 0.05 or p < 0.01). Molecular analyses revealed that XYP suppressed TAK1 expression and p38/NF-κB phosphorylation, and strengthened the interaction between lncRNA-Nespas and TAK1 in vivo. These regulatory effects were recapitulated in LPS/ATP-challenged BV2 microglia and hyperosmotic stress-exposed human corneal epithelial cells. Of note, genetic silencing of lncRNA-Nespas significantly reversed the anti-inflammatory actions of XYP. Collectively, XYP alleviates depression-associated DED by targeting the lncRNA-Nespas/TAK1 signaling axis, which suppresses inflammation in both the central nervous system and ocular tissues.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.